ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,673.58
      1.35%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      11/01/20114:16PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/01/20118:18AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/01/20116:00AMPR Newswire (US)Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/27/20116:00PMPR Newswire (US)Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/21/20116:00PMPR Newswire (US)Data From Phase 2 Clinical Studies of Telotristat Etiprate in Patients With Carcinoid Syndrome to be Presented at North Ameri...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/07/20119:00AMMarketwiredAnalyst View, Impact of Global Events - Research Report on Metabolix, Inc. and Lexicon Pharmaceuticals, Inc.NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/13/20116:15AMPR Newswire (US)LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy SubjectsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/13/20116:00AMPR Newswire (US)Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual MeetingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/06/20116:00AMPR Newswire (US)Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/30/20116:00AMPR Newswire (US)Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/15/201110:27AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/15/20116:12AMEdgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/15/20116:11AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/11/20116:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/10/20116:00PMPR Newswire (US)Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journa...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20116:04AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20116:04AMEdgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20116:04AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20116:00AMPR Newswire (US)Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid SyndromeNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/08/20116:00PMPR Newswire (US)Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/04/20116:00PMPR Newswire (US)Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2011 Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/28/20116:00AMPR Newswire (US)Lexicon's IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical TrialNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/27/20116:00AMPR Newswire (US)Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/31/20116:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/26/20114:18PMEdgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/09/20116:00AMPR Newswire (US)Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D DayNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/05/20114:30PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/03/20118:16AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/03/20116:00AMPR Newswire (US)Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20114:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX

      Your Recent History

      BOV
      FESA4
      FERBASA PN
      Delayed Upgrade Clock